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Summary and Implications 
Double stranded RNA was synthesized in vitro and was 
delivered by reverse gavage (RG) compared to traditional 
intramuscular injection (IM) 3 days prior to challenge with a 
lethal dose of WSSV in both groups. 
 
Introduction 
Double-stranded RNA (dsRNA) can serve as a potent 
trigger for an antiviral RNA interference (RNAi) response 
and has been shown to protect a variety of penaeid shrimp 
species from infection with viruses including White Spot 
Syndrome Virus (WSSV).  WSSV is one of the most 
devastating viral agents in the shrimp culture industry.  
There are no available treatments for WSSV but biosecurity 
systems have been successful.  The aim of this study was to 
test the efficacy of dsRNA against the WSSV gene, VP19, 
to protect Litopenaeus vannamei from disease when 
delivered directly to the digestive tract. This study was 
conducted by delivering VP19 dsRNA through reverse 
gavage (RG) compared to traditional intramuscular injection 
(IM).  
 
Materials and Methods 
 Double-stranded RNA targeting VP19 was generated 
by in vitro transcription.VP19 dsRNA was mixed with red 
food color to facilitate the observation of dsRNA 
introduction into the gut. 
 Specific Pathogen Free (SPF) 3- 5 gram juvenile L. 
vannamei were acquired from Shrimp Improvement 
Systems (SIS) and divided into 3 groups of 10 shrimp with 
3 replicates in each group ( n = 90 ) except 1 replicate in 
negative control group (n=10). Animals were fasted for 24 h 
prior to treatment. Treatment groups were received VP19 
dsRNA 2 ug/ shrimp either by RG or IM. At 3 days post-
VP19dsRNA injection, shrimp in each treatment group and 
positive control animals were challenged with WSSV.  
Mortality was observed for 17 days post WSSV challenge. 
Dead and moribund shrimp were tested for the presence of 
WSSV by quantitative PCR (qPCR).  
 
Results and Discussion 
 Animals in the VP19 dsRNA RG, VP19 dsRNA IM, 
and positive control groups showed survival rates of 100%, 
96.5% and 3.45%, respectively (Fig. 1). qPCR revealed that 
WSSV copies in RG and IM vaccinated group were 
significantly different (p<0.05) from the positive control 
group with 2.36x10
2
, 1.96x10
2
 and 2.56x10
7
copies, 
respectively (Fig. 2) 
 
             
 
Fig 1. Survival following vaccination via IM or RG.              Fig 2. Confirmation of differential expression of                  
       WSSV by qPCR.                                                                          
